Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience

Leukemia. 2010 Jul;24(7):1386-8. doi: 10.1038/leu.2010.112. Epub 2010 May 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child
  • Child, Preschool
  • Chromosomes, Human, Pair 16 / genetics
  • Female
  • France
  • Gene Rearrangement
  • Humans
  • Leukemia, Myeloid, Acute / diagnosis*
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / genetics*
  • Male
  • Middle Aged
  • Neoplasm, Residual / diagnosis*
  • Neoplasm, Residual / drug therapy
  • Neoplasm, Residual / genetics*
  • Oncogene Proteins, Fusion / genetics*
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome
  • Young Adult

Substances

  • CBFbeta-MYH11 fusion protein
  • Oncogene Proteins, Fusion